Cite
HARVARD Citation
Naqash, A. et al. (n.d.). 32 C-reactive protein (CRP) as a prognostic biomarker in advanced non-small cell lung cancer treated with immune checkpoint inhibitors. Results from a multi-center international observational study. Journal for immunotherapy of cancer. p. A31. [Online].